Athwal T, Huang W, Mukherjee R, Latawiec D, Chvanov M, Clarke R, Smith K, Campbell F, Merriman C, Criddle D, Sutton R, Neoptolemos J, Vlatković N
Department of Molecular and Clinical Cancer Medicine, Institute for Translational Medicine, University of Liverpool, Cancer Research Centre, Liverpool, UK.
1] Liverpool NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, University of Liverpool, Liverpool, UK [2] Sichuan Provincial Pancreatitis Centre, West China Hospital, Sichuan University, Chengdu, China.
Cell Death Dis. 2014 Apr 10;5(4):e1165. doi: 10.1038/cddis.2014.120.
Hereditary pancreatitis (HP) is an autosomal dominant disease that displays the features of both acute and chronic pancreatitis. Mutations in human cationic trypsinogen (PRSS1) are associated with HP and have provided some insight into the pathogenesis of pancreatitis, but mechanisms responsible for the initiation of pancreatitis have not been elucidated and the role of apoptosis and necrosis has been much debated. However, it has been generally accepted that trypsinogen, prematurely activated within the pancreatic acinar cell, has a major role in the initiation process. Functional studies of HP have been limited by the absence of an experimental system that authentically mimics disease development. We therefore developed a novel transgenic murine model system using wild-type (WT) human PRSS1 or two HP-associated mutants (R122H and N29I) to determine whether expression of human cationic trypsinogen in murine acinar cells promotes pancreatitis. The rat elastase promoter was used to target transgene expression to pancreatic acinar cells in three transgenic strains that were generated: Tg(Ela-PRSS1)NV, Tg(Ela-PRSS1R122H)NV and Tg(Ela-PRSS1N29I)NV. Mice were analysed histologically, immunohistochemically and biochemically. We found that transgene expression is restricted to pancreatic acinar cells and transgenic PRSS1 proteins are targeted to the pancreatic secretory pathway. Animals from all transgenic strains developed pancreatitis characterised by acinar cell vacuolisation, inflammatory infiltrates and fibrosis. Transgenic animals also developed more severe pancreatitis upon treatment with low-dose cerulein than controls, displaying significantly higher scores for oedema, inflammation and overall histopathology. Expression of PRSS1, WT or mutant, in acinar cells increased apoptosis in pancreatic tissues and isolated acinar cells. Moreover, studies of isolated acinar cells demonstrated that transgene expression promotes apoptosis rather than necrosis. We therefore conclude that expression of WT or mutant human PRSS1 in murine acinar cells induces apoptosis and is sufficient to promote spontaneous pancreatitis, which is enhanced in response to cellular insult.
遗传性胰腺炎(HP)是一种常染色体显性疾病,兼具急性和慢性胰腺炎的特征。人类阳离子胰蛋白酶原(PRSS1)的突变与HP相关,这为胰腺炎的发病机制提供了一些见解,但胰腺炎起始的相关机制尚未阐明,细胞凋亡和坏死的作用也备受争议。然而,人们普遍认为,在胰腺腺泡细胞内过早激活的胰蛋白酶原在起始过程中起主要作用。由于缺乏能真实模拟疾病发展的实验系统,HP的功能研究受到限制。因此,我们构建了一种新型转基因小鼠模型系统,使用野生型(WT)人类PRSS1或两个与HP相关的突变体(R122H和N29I),以确定人类阳离子胰蛋白酶原在小鼠腺泡细胞中的表达是否会引发胰腺炎。大鼠弹性蛋白酶启动子用于将转基因表达靶向到所构建的三种转基因品系的胰腺腺泡细胞中:Tg(Ela-PRSS1)NV、Tg(Ela-PRSS1R122H)NV和Tg(Ela-PRSS1N29I)NV。对小鼠进行了组织学、免疫组织化学和生物化学分析。我们发现转基因表达仅限于胰腺腺泡细胞,转基因PRSS1蛋白靶向于胰腺分泌途径。所有转基因品系的动物都发生了胰腺炎,其特征为腺泡细胞空泡化、炎性浸润和纤维化。与对照组相比,转基因动物在用低剂量雨蛙肽处理后还会发生更严重的胰腺炎,在水肿、炎症和整体组织病理学方面的评分显著更高。WT或突变型PRSS1在腺泡细胞中的表达增加了胰腺组织和分离的腺泡细胞中的细胞凋亡。此外,对分离的腺泡细胞的研究表明,转基因表达促进细胞凋亡而非坏死。因此,我们得出结论,WT或突变型人类PRSS1在小鼠腺泡细胞中的表达诱导细胞凋亡,足以促进自发性胰腺炎,并且在细胞受到损伤时会加剧。